Haemonetics Corporation (HAE) Dividend History

Company News

• Patient Blood Management Market Growth Analysis Report 2025-2033 | AI-Driven Analytics Revolutionize Blood Management Strategies, Blockchain Enhances Supply Transparency and Safety

  The Patient Blood Management market is projected to grow from $13.9 billion in 2025 to $23 billion by 2033, driven by AI-enhanced analytics, autologous transfusion technologies, and advancements in blood conservation techniques.

  GlobeNewswire Inc.

  Featured Companies: BDX
• Haemonetics (HAE) Q1 Revenue Falls 4%

  Haemonetics reported Q1 FY2026 financial results with revenue of $321.4 million, missing analyst expectations. Despite revenue decline, the company showed strong organic growth in Plasma and Hospital segments and improved margins.

  The Motley Fool
• Is Phibro (PAHC) Stock Worth Retaining in Your Portfolio Now?

  Phibro Animal Health Corporation's robust sales of vaccines and medicated feed additives (MFAs) are driving growth in its Animal Health business. The company's focus on advancing nutritional specialties and vaccine technologies, along with a new vaccine production unit, instills optimism. However, adverse macroeconomic impacts and growing competition from generic alternatives are concerns.

  Zacks Investment Research

  Featured Companies: AVNS PAHC TFX
• Haemonetics' Strategic Moves Poised To Boost Margins And Earnings, Says Analyst

  Needham & Co. analyst Mike Matson upgraded Haemonetics Corporation (NYSE:HAE) from Hold to Buy with a price target of $112. The analyst says that Haemonetics has reaffirmed its “high-20%” FY26 operating margin goal. To reach this, the company must improve by approximately 600 basis points from its FY24 margin of 21.1%, writes the analyst. While the analyst earlier doubted the company’s ability to reach this target, the product mix analysis has bolstered their confidence. The analyst has identified two key factors influencing the company’s gross margin, which includes ...Full story available on Benzinga.com

  Benzinga

  Featured Companies: NBSM XHE
• 3 Undervalued Stocks to Buy as Optimism Persists Despite Rate-Cut Uncertainty

  Investing.com

  Featured Companies: CVX HES STM